DIAMOND STUART purchased 4.08K shares of BIOAFFINITY TECHNOLOGIES, INC. on the open market
Open‑market purchases signal personal conviction.
P · 1 purchase
Filed: 12/2/2022ACC: 0001493152-22-034366
Director
Since Aug 2022
+12.24K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
12.24K acquired
Non-Derivative Transactions1
Common Stock, par value $0.007
Direct
Shares
+4.08K
Price / share
—
Trade value
—
% of position
New position
8/31/2022
0.00→4.08K
Total
Net shares
+4.08K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.007 Direct | 8/31/2022 | P · Purchase | +4.08K | — | — | New position | 0.00 | 4.08K |
| Total | +4.08K | $0.00 | ||||||
Derivative Transactions2
Warrants (right to buy)
Direct
Converts to
Common Stock
4.08K shares
Shares
+4.08K
Strike price
7.35
Held after
4.08K
Exercisable
—
8/31/2022
Non-tradeable Warrants (right to buy)
Direct
Converts to
Common Stock
4.08K shares
Shares
+4.08K
Strike price
7.656
Held after
4.08K
Exercisable
—
8/31/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to buy) Direct | Common Stock4.08K shares | 8/31/2022 | P · Purchase | +4.08K | 7.35 | — | 4.08K |
| Non-tradeable Warrants (right to buy) Direct | Common Stock4.08K shares | 8/31/2022 | P · Purchase | +4.08K | 7.656 | — | 4.08K |